Dr Sanjay Singh, CEO of Gennova Biopharmaceuticals, said the firm will do preclinical and phase 1 vaccine tests in India, where multiple Nipah outbreaks have been reported over the past 20 years.

(Image Credits: Pixabay) Gennova Biopharmaceuticals Ltd. on Tuesday announced that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), a subsidiary of Emcure ...

Gennova Biopharmaceuticals, a unit of Emcure Pharmaceuticals, has expanded its collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of a ...

Currently there are no authorized vaccines or targeted drugs against Nipah, which kills an estimated 75% of those it infects.